Nasonex (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in the nasal mucosa, altering gene transcription to suppress inflammatory cytokine production, reduce edema, and inhibit immune‑cell activation, which together diminish nasal inflammation.

The specific dose and frequency are determined by the prescribing clinician based on the patient’s age, severity of symptoms, and indication. Patients should follow the prescriber’s instructions and the product labeling.

Safety data for mometasone furoate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex (mometasone furoate) is a potent, once‑daily nasal corticosteroid with high receptor affinity, offering effective symptom control for allergic rhinitis and nasal polyps. Compared with older agents such as fluticasone or budesonide, it provides comparable efficacy with low systemic absorption, though individual response may vary.

Store Nasonex at room temperature, below 25 °C, in the original packaging to protect it from moisture and direct heat. Keep the spray bottle tightly closed when not in use and avoid freezing.

Nasonex is administered as a nasal spray. The patient should gently blow the nose, insert the tip into one nostril, close the opposite nostril, and spray the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed.

Although uncommon, serious adverse events can include nasal septal perforation, severe allergic reactions such as anaphylaxis, and vision changes. Patients should seek immediate medical attention if they experience nosebleeds that do not stop, persistent eye problems, or signs of a severe allergic response.

Nasonex should not be used by individuals with known hypersensitivity to mometasone furoate or any component of the formulation. Caution is also advised for patients with active untreated fungal, bacterial, or viral infections of the nasal passages, and it is generally avoided in children under the approved age without medical guidance.